Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: Melatonin for Delirium Prevention in Hospitalized Older Adults
NCT06509191Phase 3Recruiting
- Sponsor
- Sultan Qaboos University
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in delirium, sponsored by Sultan Qaboos University. Started Sep 2024; status: recruiting.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06509191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06509191.